Thank you for your interest in post-marketing study information. The Post-Marketing Study Registration System on this website has ceased updates as of January 1, 2025, and related information is no longer provided on this platform.

For inquiries about post-marketing studies or related research information, we recommend exploring other resources that provide clinical trial information, such as the Taiwan Clinical Trials (TaiwanClinicalTrials.tw), clinical trial centers at major hospitals, or the website of Center for Drug Evaluation (https://www1.cde.org.tw/ct_taiwan/introduction.html).

We appreciate your understanding and continued support!

Company Name	Title of Study	Update Date
Bayer Taiwan Co., Ltd.	RAPIT/ Safety and Effectiveness of Xofigo® (Radium-223 dichloride) in Routine Clinical Practice Settings in Taiwan)	2022-07-07
Bayer Taiwan Co., Ltd.	XARETO / Xarelto® for the prevention of stroke and non-central nervous systemic embolism in non-valvular atrial fibrillation with REnal impairment in Taiwanese population.	2022-06-28
Pfizer	A Phase 4, Open-Label, Randomized study of two Inotuzumab ozogamicin dose levels in adult patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia eligible for Hematopoietic Stem cell Transplantation and who have Risk factor(s) for veno-occlusive Disease.	2022-01-20
AbbVie Biopharmaceuticals GmbH Taiwan Branch	Global cross-sectional burden-of-illness study in adolescent and adult patients with atopic dermatitis (MEASURE-AD)	2021-09-06
AbbVie Biopharmaceuticals GmbH Taiwan Branch	Real World Treatment Patterns and Clinical Outcomes in Unfit AML Patients Receiving First Line Systemic Treatment or Best.	2021-05-31
Pfizer	TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS OUTCOMES SURVEY (THAOS): A GLOBAL, MULTI-CENTER, LONGITUDINAL, OBSERVATIONAL SURVEY OF PATIENTS WITH DOCUMENTED TRANSTHYRETIN (TTR) MUTATIONS OR WILD-TYPE TTR AMYLOIDOSIS	2021-03-02
Pfizer	Thromboembolic and Bleeding Risks of Apixaban, Rivaroxaban and Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation	2021-03-02
Pfizer	Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan, A Retrospective NHIA Database Analysis	2020-11-24
Bayer Taiwan Co., Ltd.	AURIGA / An observationAl stUdy pRogram to InvestiGate the effectiveness of intravitreal Aflibercept in diabetic macular edema and/or macular edema secondary to retinal vein occlusion in a real world setting.	2020-06-19
Pfizer	Treatment Patterns And Clinical Outcomes Among Taiwanese Patients Receiving Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.	2020-06-19